Dyadic International DYAI
NASDAQ DYAI
$0.49 -0.02 (-3.66%)
As of: Sep 10, 2026 · 3:59 PM EDT

Dyadic International (DYAI) Short-term Investments (2017 - 2026)

Dyadic International's (DYAI) quarterly Short-term Investments came in at $1.4 million in Q1 2026, down 40.42% year-over-year from $2.3 million in Q1 2025, and down 49.57% quarter-over-quarter from $2.7 million in Q4 2025.

Analysis

Dyadic International (DYAI) Short-term Investments (2017 - 2026) Analysis & Trends

Dyadic International has disclosed Short-term Investments across 10 years of filings, most recently posting $1.4 million for Q1 2026.

  • In Q1 2026, Short-term Investments fell 40.42% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (down 40.42% YoY), while the FY2025 annual figure was $2.7 million, down 2.1% from the prior year.
  • Short-term Investments came in at $1.4 million for Q1 2026 at Dyadic International, down from $2.7 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $3.0 billion in Q1 2022 to a low of $748290.0 in Q4 2023.
  • Average Short-term Investments over 5 years is $181.2 million, with a median of $4.0 million recorded in 2024.
  • Year-over-year, Short-term Investments jumped 21208.95% in 2022 and tumbled 99.82% in 2023.
  • Over 5 years, Short-term Investments stood at $6.8 million in 2022, then sank by 89.07% to $748290.0 in 2023, then jumped by 268.38% to $2.8 million in 2024, then decreased by 2.1% to $2.7 million in 2025, then tumbled by 49.57% to $1.4 million in 2026.
  • Per Business Quant data, the three most recent Short-term Investments figures were $1.4 million in Q1 2026, $2.7 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn
10 Dyadic International 17.78 Mn 9.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.36 Mn
Dec 31, 2025 2.70 Mn
Sep 30, 2025 3.10 Mn
Jun 30, 2025 6.90 Mn
Mar 31, 2025 2.28 Mn
Dec 31, 2024 2.76 Mn
Sep 30, 2024 4.00 Mn
Jun 30, 2024 3.96 Mn
Mar 31, 2024 1.47 Mn
Dec 31, 2023 748,290.00
Sep 30, 2023 772,804.00
Jun 30, 2023 4.29 Mn
Mar 31, 2023 5.36 Mn
Dec 31, 2022 6.85 Mn
Sep 30, 2022 7.46 Mn
Jun 30, 2022 6.16 Mn
Mar 31, 2022 3.02 Bn
Dec 31, 2021 4.51 Mn
Sep 30, 2021 9.09 Mn
Jun 30, 2021 11.58 Mn